Lonza Group (Capsugel), Headquarters: Basel, Switzerland, Estimated Global Market Share: 22-25%As the world's largest empty capsule manufacturer, it has the most comprehensive product line covering pharmaceutical-grade gelatin capsules, HPMC and pullulan plant-based capsules, as well as high-value-added specialty capsules such as enteric-coated, modified-release and moisture-resistant types. It is a pioneer in sustainable plant-based capsule technology, with GMP/FDA/EMA certified production bases deployed globally. Its industry-leading R&D team focuses on capsule formulation innovation and compatibility testing with active pharmaceutical ingredients (APIs). The acquisition of Capsugel in 2017 further consolidated its leading position in the global market, and it has a mature global distribution network to provide one-stop solutions for pharmaceutical and nutraceutical enterprises worldwide.
ACG Worldwide, Headquarters: Mumbai, India, Estimated Global Market Share: 15-18%It is the top empty capsule manufacturer in Asia and a core player in the global market, with a complete product matrix including hard gelatin capsules, vegetarian capsules (HPMC/pullulan), enteric-coated capsules and modified-release capsules. It independently developed ACGcaps™ HD capsules for hygroscopic and moisture-sensitive APIs, filling the market gap. The enterprise has a presence in more than 100 countries and regions across Asia, Europe, North America and Latin America, with advanced R&D centers dedicated to capsule material innovation and production process optimization. It realizes cost-effective large-scale production while strictly abiding by international quality standards, forming a unique cost-quality dual advantage in the mid-to-high-end market.
Qualicaps, Headquarters: Tokyo, Japan, Estimated Global Market Share: 10-12%Famous for its ultra-strict zero-defect quality control philosophy, it is the benchmark enterprise for quality in the global empty capsule industry, with its products widely used in critical drug formulation fields such as cardiovascular and neurological drugs. It has unique core expertise in inhalation-grade specialty capsules (Quali-V® brand), whose products have excellent barrier properties and stable performance under different climatic and storage conditions. It has built global production bases in the United States, Germany, China and Southeast Asia, realizing localized production and distribution in major pharmaceutical markets, and its pharmaceutical-grade capsule products account for a high proportion of its total output, with strong technical matching capabilities for complex drug formulations.
Suheung Capsule, Headquarters: Seoul, South Korea, Estimated Global Market Share: 6-8%As the leading pharmaceutical capsule enterprise in South Korea, it has independent research and development capabilities for innovative production equipment, and its production line defect rate is less than 0.001%, ranking the top in the global industry. It focuses on high-purity pharmaceutical-grade gelatin capsules and plant-based capsules, with strict raw material screening and production process control to ensure the high uniformity of capsule size and performance. Its products are exported to more than 50 countries and regions across Europe, Asia and Africa, and it has a professional technical service team to provide customized capsule solutions for customers with complex formulation challenges, with a high reputation in the mid-to-high-end pharmaceutical capsule market.
CapsCanada Corporation, Headquarters: Ontario, Canada, Estimated Global Market Share: 4-6%It is the core player in the North American empty capsule market, focusing on providing customized capsule solutions for pharmaceutical and nutraceutical enterprises, with strong advantages in hard-to-fill formulation matching and custom-sized capsule production. Its product line includes gelatin capsules, HPMC vegetarian capsules and enteric-coated capsules, all of which comply with Canadian Health Canada, FDA and EMA international quality standards. It has a perfect local after-sales service system in North America, with fast response speed to customer needs, and is the preferred cooperative supplier for many small and medium-sized pharmaceutical and nutraceutical brands in North America due to its flexible production mode and personalized customization capabilities.
Sunil Healthcare Limited, Headquarters: Mumbai, India, Estimated Global Market Share: 3-5%As the second-largest empty capsule manufacturer in India, it has a large-scale production capacity of more than 10 billion capsules annually, with obvious scale effect and price competitiveness. Its product line covers gelatin capsules and HPMC vegetarian capsules, serving pharmaceutical, nutraceutical and cosmeceutical multiple downstream sectors, with a balanced product layout in mid-end and economical markets. It has modern production facilities and an efficient logistics distribution system, with fast delivery efficiency and stable supply capacity, and is the core supplier of generic drug enterprises in South Asia, Southeast Asia and Africa. In recent years, it has accelerated the expansion of plant-based capsule production capacity to meet the growing global demand for vegetarian capsules.
Farmacapsulas SA, Headquarters: Barcelona, Spain, Estimated Global Market Share: 3-4%It is the regional leader of the European empty capsule market, with ISO 9001 and ISO 15378 double certification, and its products are strictly in line with EU pharmaceutical quality standards. It focuses on the research and development and production of high-end pharmaceutical-grade gelatin capsules and plant-based capsules, with core advantages in the production of specialty capsules for sensitive APIs and probiotic formulations, whose products can effectively protect the activity of active ingredients. Its core market covers the EU, Middle East and North Africa, with a long-standing reputation for product quality and reliability in the European pharmaceutical industry, and it has a stable cooperative relationship with many well-known European pharmaceutical enterprises.
Bright Pharma Caps Inc., Headquarters: New Jersey, USA, Estimated Global Market Share: 2-3%As a professional empty capsule manufacturer rooted in the North American market, it is committed to innovative capsule design and product development, and launched the world's first certified organic plant-based capsules in August 2023, filling the gap in the global organic capsule market. Its product advantages focus on colored, printed and hard-to-fill formulation matching capsules, with strong independent customization capabilities for capsule appearance and performance. It has close strategic cooperation with many North American pharmaceutical and nutraceutical brands, with a short supply chain and fast localized production and delivery capabilities, and attaches great importance to customer-specific requirements with a high turnaround efficiency for customized orders.
Evonik Industries, Headquarters: Essen, Germany, Estimated Global Market Share: 2-3%As a global giant in chemical and pharmaceutical raw materials, it is not a pure capsule manufacturer, but its core advantage lies in the research and development and production of high-tech functional empty capsules based on advanced drug delivery systems. Its representative products include Eudragit® coated enteric capsules and sustained-release capsules, which can accurately control the drug release site and speed in the human body, and are widely used in the formulation of high-value-added innovative drugs. It has strong material R&D capabilities, and its capsule products are highly matched with complex innovative drug formulations, with a high market share in the global high-end functional capsule market.
Huangshan Capsule Co., Ltd., Headquarters: Huangshan, China, Estimated Global Market Share: 2-3%It is the leading listed empty capsule manufacturer in China, with a complete product line of pharmaceutical-grade gelatin capsules and HPMC vegetarian capsules, all of which have passed GMP, FDA and CEP international certifications. Its products are exported to more than 30 countries and regions across Europe, Asia and Africa, and it has obvious cost advantages in large-scale production, with stable product quality and high uniformity. In recent years, it has accelerated the R&D and production capacity expansion of plant-based capsules (HPMC/pullulan), and continuously optimized the production process and raw material screening system, gradually increasing its market share in the global mid-to-high-end empty capsule market, and is a core representative of Chinese empty capsule enterprises in the international market.